Clinics and Research in Hepatology and Gastroenterology

Papers
(The TQCC of Clinics and Research in Hepatology and Gastroenterology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends54
Epidemiology of hepatitis C virus infection52
Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy46
Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea45
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study43
Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease42
The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis40
Covid-19 in liver transplant recipients: the French SOT COVID registry40
Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?38
Uncommon presentation of COVID-19: Gastrointestinal bleeding30
HCV virology and diagnosis29
Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study25
Diarrhea: An underestimated symptom in Coronavirus disease 201925
Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials24
A case of COVID-19 patient with the diarrhea as initial symptom and literature review24
TIPS for management of portal-hypertension-related complications in patients with cirrhosis23
Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis22
Efficacy and safety of obeticholic acid in liver disease—A systematic review and meta-analysis22
Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy22
Homeostatic regulation of food intake21
The occurrence of diarrhea in COVID-19 patients21
Autoimmune hepatitis developing after COVID 19 vaccine: Presumed guilty?21
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study21
Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer21
LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis20
Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal19
Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model19
Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid18
Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort18
Hepatitis B virus American genotypes: Pathogenic variants ?18
Acute liver failure requiring transplantation caused by ulipristal acetate18
Microbiome and pancreatic ductal adenocarcinoma18
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)18
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma17
Sinusoidal obstruction syndrome17
NAFLD: genetics and its clinical implications16
An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis16
Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients16
Statins use and the prognosis of colorectal cancer: a meta-analysis16
Self-limited gastrointestinal bleeding in COVID-1916
Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound15
Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction15
Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target15
Factors associated with non adherence to a gluten free diet in adult with celiac disease: A survey assessed by BIAGI score15
Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p5315
MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer15
Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyo14
Effect of novel glucose lowering agents on non-alcoholic fatty liver disease: A systematic review and meta-analysis14
The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice14
Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma14
Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children14
Acute liver failure due to DGUOK deficiency–is liver transplantation justified?14
Prospective evaluation of third-generation small bowel capsule endoscopy videos by independent readers demonstrates poor reproducibility of cleanliness classifications14
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient13
Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus13
COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms12
Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis12
MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer12
Clinicopathological features, risk of lymph node metastasis and survival outcome of synchronous multiple early gastric cancer12
Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials12
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study12
Risk factors for concomitant infectious pancreatic necrosis in patients with severe acute pancreatitis: A systematic review and meta-analysis12
Prevalence and clinical features of hepatitis E virus infection in pregnant women: A large cohort study in Inner Mongolia, China12
Impact of the first Covid-19 outbreak on liver transplantation activity in France: A snapshot12
Inhibition of β-glucosidase overcomes gastric cancer chemoresistance through inducing lysosomal dysfunction12
The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase12
Vitamin D deficiency negatively affects both the intestinal epithelial integrity and bone metabolism in children with Celiac disease12
Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review12
The gut microbiome as a target for adjuvant therapy in insomnia disorder12
Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial12
LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival12
The effect of reminiscence therapy-involved care on anxiety, depression, life quality and survival in colorectal cancer patients12
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study11
“Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study”11
The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study11
World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure11
Treatment of hepatitis C virus infection11
Prevalence of gallstone in Mainland China: A meta-analysis of cross-sectional studies11
MSI colorectal cancer, all you need to know11
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy11
The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study11
A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire11
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study11
Congenital portosystemic shunts10
Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients10
Is it time for global adoption of endoscopic retrograde appendicitis therapy of acute appendicitis?10
Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?10
Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era10
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-1910
The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers10
Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients10
Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic10
Epstein-Barr virus-negative inflammatory pseudotumor-like variant of follicular dendritic cell sarcoma of the liver: A case report and literature review10
Expectations of IBS patients concerning disease and healthcare providers: Results of a prospective survey among members of a French patients’ association10
Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study10
Refractory celiac disease and COVID-19 outbreak: Findings from a high incidence scenario in Northern Italy10
Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study10
Long noncoding RNA PVT1 promotes tumour progression via the miR-128/ZEB1 axis and predicts poor prognosis in esophageal cancer10
Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma10
Quality criteria for the measurement of liver stiffness10
Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial9
Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience9
Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area9
Circular RNA circAFF2 accelerates gastric cancer development by activating miR-6894-5p and regulating ANTXR 1 expression9
Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 20199
Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease9
Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: A “menage à trois” !9
Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study9
Drug induced liver injury and vascular liver disease9
Anastomotic bilio-biliary stricture after adult liver transplantation: A retrospective study over 20 years in a single center9
The research progress of Wnt/β-catenin signaling pathway in colorectal cancer9
Budd-Chiari syndrome9
Clinical interpretation of PRSS1 variants in patients with pancreatitis9
Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-199
Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study9
A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy9
Acute liver failure and HELLP syndrome: A clinical case and literature review8
Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis8
Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases8
The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients8
Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis8
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports8
Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis8
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles’ heel?8
Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients8
Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease8
Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease8
Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease8
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis8
Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis8
Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-5118
Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survi8
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response8
Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study8
Non-small-bowel lesions identification by capsule endoscopy: A single centre retrospective study8
Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners8
LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients8
Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery8
B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis8
The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis8
Concurrence of HBV infection and non-alcoholic fatty liver disease is associated with higher prevalence of chronic kidney disease8
Myosteatosis in nonalcoholic fatty liver disease: An exploratory study8
Present and future management of viral hepatitis B and C in children8
Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis8
Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: A prospective study in a tertiary university hospital8
Adverse events after biliary sphincterotomy: Does the electric current mode make a difference? A systematic review and meta-analysis of randomized controlled trials8
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease8
Surgical management of oligometastatic disease in gastric cancer8
Ischemic cholangiopathy: An update8
Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-018
Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study7
Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease7
Low serum alkaline phosphatase levels in patients with chronic liver diseases: Possible contributions to disease pathogenesis7
Colon ischemia: A comprehensive review7
Trimetazidine alone or in combination with gemcitabine and/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells7
Characteristics and outcome of primary Budd-Chiari syndrome due to Behçet's syndrome7
Immune checkpoint inhibitor induced colitis: A nationwide population-based study7
Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model7
Chronic hepatitis E in an immunocompetent patient7
Italian migrants study: An HCV and HBV micro-elimination pilot project7
Cellular communication network factor 1 (CCN1) knockdown exerts a protective effect for hepatic ischemia/reperfusion injury by deactivating the MEK/ERK pathway7
Covid19 vaccination-associated portal vein thrombosis—An interdisciplinary clinical challenge7
Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis7
Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis7
Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patie7
A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma7
Duration from the first pale stool to portoenterostomy is prognostic in biliary atresia. Comparison with age at portoenterostomy7
Advances in cell death - related signaling pathways in acute-on-chronic liver failure7
Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors7
Efficacy and safety of islet autotransplantation after total pancreatectomy in chronic pancreatitis: A systematic review and meta-analysis including 17 studies7
Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy7
Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis7
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma7
Metabolic-associated fatty liver disease and the risk of cardiovascular disease7
CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis7
Methylprednisolone-related liver injury: A descriptive study using the French pharmacovigilance database7
Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-197
Non-invasive diagnosis and follow-up of rare genetic liver diseases7
Eosinophilic colitis in adults7
Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review7
Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biops7
Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?6
COVID-19-associated secondary sclerosing cholangitis – A case series of 4 patients6
Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn’s disease6
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality6
The endless history or search for the true role of alloantibodies in liver transplantation6
Experience with the use of a hemostatic powder in 152 patients undergoing urgent endoscopy for gastrointestinal bleeding6
Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma6
Liver transplantation for critically ill cirrhotic patients: Results from the French transplant registry6
Non-invasive diagnosis and follow-up of autoimmune hepatitis6
Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family6
Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus6
Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients6
High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study6
Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis6
Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy6
TIPS for patients with early HCC: A bridge to liver transplantation6
Pulmonary infection after hepatic resection: Associated factors and impact on outcomes6
Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-6
Clinicopathological assessment of steatohepatitic hepatocellular carcinoma6
Excessive anxiety in IBD patients is unnecessary for COVID-196
Sodium taurocholate co-transporting polypeptide deficiency6
Non-coding RNAs as biomarkers for hepatocellular carcinoma—A systematic review6
Partial major hepatectomy with cyst fenestration for polycystic liver disease: Indications, short and long-term outcomes6
Transarterial chemoembolization (TACE) plus apatinib-combined therapy versus TACE alone in the treatment of intermediate to advanced hepatocellular carcinoma patients: A real-world study6
Long-term results of pediatric liver transplantation for autoimmune liver disease6
Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials6
The clinical effect of early enteral nutrition in liver-transplanted patients: a systematic review and meta-analysis6
Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s6
Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia – Randomized placebo controlled trial6
Association of shear-wave elastography with clinical outcomes post-liver transplantation5
Red flags for the diagnosis of autoimmune gastritis5
HLA matching and rabbit antithymocyte globulin as induction therapy to avoid multiple forms of rejection after a third liver transplantation5
The role of miRNA125b in the progression of hepatocellular carcinoma5
Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease5
Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?5
The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma5
Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil5
Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience5
A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-CO5
Comparison of sodium-glucose cotransporter-2 inhibitors and thiazolidinediones for management of non-alcoholic fatty liver disease: A systematic review and meta-analysis5
New epidemiologic trends in cholangiocarcinoma5
Liver health literacy and social stigma of liver disease: A general population e-survey5
Gender differences in liver fibrosis among patients younger than 50 years: A retrospective cohort study5
Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database5
Outcomes of endoscopic submucosal dissection for early esophageal and gastric cardia adenocarcinomas5
Hereditary diffuse gastric cancer (HDGC). An overview5
Adult diffuse hepatic hemangiomatosis: A case report and review of the literature5
The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study5
Adenosquamous carcinoma of the pancreas5
Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients5
Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators5
Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival5
Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil5
Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,5
The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review.5
Association between prior appendectomy and the risk and course of Crohn's disease: A systematic review and meta-analysis5
Angioedema with severe acute abdominal pain: Think of hereditary angioedema5
Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways5
Endoscopic submucosal dissection or piecemeal endoscopic mucosal resection for large superficial colorectal lesions: A cost effectiveness study5
Clinical characteristics and outcomes of COVID-19 patients with hypoxic hepatitis5
Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro5
A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings5
Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance5
Effect of implementing a regional referral network on surgical referral rate of benign polyps found during a colorectal cancer screening program: A population-based study5
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma5
Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study5
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal5
TSHZ3 functions as a tumor suppressor by DNA methylation in colorectal cancer5
Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study5
0.04955005645752